A Study of ASP3082 in Adults With Advanced Solid Tumors
Clinical trial NCT05382559 · RECRUITING
Trial details
- NCT number
- NCT05382559
- Sponsor
- Astellas Pharma Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-08
- Primary completion
- 2028-12-31
- Enrollment
- 681
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.